Comparison of the effects of moxifloxacin (0.5%) and gatifloxacin (0.3%) ophthalmic solutions on corneal sensitivity

被引:0
|
作者
Torkildsen, G
French, S
Shapiro, A
Abelson, MB
机构
[1] Ophthalm Res Associates, N Andover, MA 01845 USA
[2] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA USA
来源
FASEB JOURNAL | 2006年 / 20卷 / 04期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:A266 / A266
页数:1
相关论文
共 50 条
  • [31] A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability (vol 20, pg 1753, 2004)
    Donnenfeld, E
    Perry, HD
    Chruscicki, DA
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (04) : 643 - 643
  • [32] Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial
    Baiza-Duran, Leopoldo
    Olvera-Montano, Oscar
    Mercado-Sesma, Arieh R.
    Oregon-Miranda, Aldo A.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (03) : 250 - 255
  • [33] Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial (vol 34, pg 250, 2018)
    Baiza-Duran, L.
    Olvera-Montano, O.
    Mercado-Sesma, A. R.
    Oregon-Miranda, A. A.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 35 (01) : 76 - 76
  • [34] Comparison of wound healing in pigmented rabbits receiving moxifloxacin or gatifloxacin after creation of corneal flap or penetrating corneal incision
    Williams, K. Keven
    Rice, Rebecca L.
    McCartney, Mitchell D.
    Wax, Martin B.
    Hiddemen, Joseph W.
    CORNEA, 2006, 25 (09) : S39 - S44
  • [35] Effect of gatifloxacin ophthalmic solution 0.3% on corneal endothelial cell counts in normal subjects and in cataract surgery patients
    Price, MO
    Price, FW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U546 - U546
  • [36] Comparison of the Effects of Ophthalmic Solutions on Human Corneal Epithelial Cells Using Fluorescent Dyes
    Xu, Manlong
    Sivak, Jacob G.
    McCanna, David J.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (09) : 794 - 802
  • [37] Comparison of topical moxifloxacin 0.5% to ciprofloxacin 0.3% in the treatment of experimental Pseudomonas aeruginosa keratitis in rabbits
    Aliprandis, ET
    Ciralsky, J
    Lai, H
    Herling, I
    Katz, HR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U640 - U640
  • [38] A comparison of travoprost 0.004%/timolol 0.5% ophthalmic solution to the concomitant administration of travoprost 0.004% and timolol 0.5% ophthalmic solutions and to timolol 0.5% ophthalmic solution alone
    Schuman, JS
    Pettigrew, SC
    Mallick, S
    Wells, DT
    Andrew, RM
    Sullivan, EK
    Landry, TA
    Bergamini, MVW
    Robertson, SM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U164 - U164
  • [39] Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers
    Hyndiuk, RA
    Eiferman, RA
    Caldwell, DR
    Rosenwasser, GO
    Santos, CI
    Katz, HR
    Badrinath, SS
    Reddy, MK
    Adenis, JP
    Klauss, V
    COhen, E
    MarechalCourtois, C
    Murta, J
    Darrell, RW
    Denis, P
    Heidemann, DH
    Insler, MS
    John, T
    Klauss, V
    Lass, JH
    Limberg, MB
    McCulley, JP
    Rosenwasser, GOD
    Rowsey, JJ
    Santos, C
    Sher, N
    Ullman, S
    Verin, P
    Wilhelmus, KR
    Wills, R
    Wolf, TC
    OPHTHALMOLOGY, 1996, 103 (11) : 1854 - 1862
  • [40] Effects of action of proparacaine and tetracaine topical ophthalmic formulations on corneal sensitivity in horses
    Sharrow-Reabe, Karen L.
    Townsend, Wendy M.
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2012, 241 (12): : 1645 - 1649